Literature DB >> 9802733

Fasting plasma glucose in screening for diabetes in the Taiwanese population.

C J Chang1, J S Wu, F H Lu, H L Lee, Y C Yang, M J Wen.   

Abstract

OBJECTIVE: To reveal the relationship between fasting and 2-h postload plasma glucose and to examine the appropriate fasting glucose cutoff as the primary screening test for diabetes. RESEARCH DESIGN AND METHODS: We recruited 5,303 subjects from preventive services of the National Cheng Kung University Hospital. Exclusion criteria were age <20 years, pregnancy, known diabetes, and a history of recent surgery, trauma, or illness. All subjects received the 75-g oral glucose tolerance test. The relationship between fasting and 2-h glucose was examined. Sensitivities, specificities, efficiency, and predictive values were assessed at different cutoffs of fasting glucose for prediction of diabetes.
RESULTS: The best fit model for the relationship between fasting and 2-h glucose was fasting glucose = 4.914-0.060 x (2-h glucose) + 0.0144 x (2-h glucose)2. From this model, the fasting glucose was 6.0 mmol/l when 2-h glucose was 11.1 mmol/l. A fasting glucose with 6.25 mmol/l gave the same diabetes prevalence as the World Health Organization 2-h glucose criterion. When 7.8 mmol/l was the fasting glucose cutoff, the sensitivity was 28.5%. Lowering the cutoff from 7.8 to 7.0 mmol/l increased the sensitivity by 11.2% and slightly reduced the specificity and positive predictive value. If the cutoffs were 6.25 and 6.0 mmol/l, the sensitivity increased and the specificity and the positive predictive value decreased accordingly.
CONCLUSIONS: Our results suggest that fasting glucose as a screening criterion for diabetes could be revised downward to 7.0 mmol/l, because the slight reduction of positive predictive value was more than balanced by an apparent increase of sensitivity and insignificant change of specificity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9802733     DOI: 10.2337/diacare.21.11.1856

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  5 in total

1.  Screening for type 2 diabetes mellitus to prevent vascular complications: updated recommendations from the Canadian Task Force on Preventive Health Care.

Authors:  Denice S Feig; Valerie A Palda; Lorraine Lipscombe
Journal:  CMAJ       Date:  2005-01-18       Impact factor: 8.262

2.  Glucose challenge test screening for prediabetes and undiagnosed diabetes.

Authors:  L S Phillips; D C Ziemer; P Kolm; W S Weintraub; V Vaccarino; M K Rhee; R Chatterjee; K M V Narayan; D D Koch
Journal:  Diabetologia       Date:  2009-06-26       Impact factor: 10.122

3.  Developing a Screening Algorithm for Type II Diabetes Mellitus in the Resource-Limited Setting of Rural Tanzania.

Authors:  Caroline West; David Ploth; Virginia Fonner; Jessie Mbwambo; Francis Fredrick; Michael Sweat
Journal:  Am J Med Sci       Date:  2016-02-10       Impact factor: 2.378

4.  New ADA criteria in the Korean population: fasting blood glucose is not enough for diagnosis of mild diabetes especially in the elderly.

Authors:  Y H Choi; Y B Ahn; K H Yoon; M I Kang; B Y Cha; K W Lee; H Y Son; S K Kang
Journal:  Korean J Intern Med       Date:  2000-12       Impact factor: 2.884

Review 5.  The Oral Glucose Tolerance Test: 100 Years Later.

Authors:  Ram Jagannathan; João Sérgio Neves; Brenda Dorcely; Stephanie T Chung; Kosuke Tamura; Mary Rhee; Michael Bergman
Journal:  Diabetes Metab Syndr Obes       Date:  2020-10-19       Impact factor: 3.168

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.